Skip to main content
SpringerLink
Log in

Place de la tomographie par émission de positons au F18-fluorodéoxyglucose couplée au scanner (TEP/TDM) dans le bilan initial des lymphomes de l’adulte

The role of PET scanning with F18-fluorodeoxyglucose in the initial assessment of adult lymphoma

  • Synthèse / Review Article
  • Published:
Oncologie

Abstract

The role of FDG-PET/CT in lymphoma is described in the various lymphoma subtypes. Its prognostic value and comparison with CECT are addressed in this review.

Résumé

Le rôle de la tomographie par émission de positons au F18-fluorodéoxyglucose (TEPFDG) couplée au scanner dans le bilan initial des lymphomes est étudié dans cette revue générale. Ses avantages par rapport au scanner conventionnel pour le bilan d’extension et sa valeur pronostique sont discutés.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Références

  1. Barrington SF, Qian W, Somer EJ, et al. (2010) Concordance between four European centres of PET reporting criteria designed for use in multicentre trials in Hodgkin lymphoma. Eur J Nucl Med Mol Imaging 37: 1824–1833

    Article  PubMed  Google Scholar 

  2. Bodet-Milin C, Kraeber-Bodere F, Moreau P, et al (2008) Investigation of FDG-PET/CT imaging to guide biopsies in the detection of histological transformation of indolent lymphoma. Haematologica 93: 471–472

    Article  PubMed  Google Scholar 

  3. Bodet-Milin C, Touzeau C, Leux C, et al. (2010) Prognostic impact of 18F-fluorodeoxyglucose-positron emission tomography in untreated mantle cell lymphoma: a retrospective study from the GOELAMS group. Eur J Nucl Med Mol Imaging 37: 1633–1642

    Article  PubMed  CAS  Google Scholar 

  4. Cahu X, Bodet-Milin C, Brissot E, et al (2011) 18F-fluorodeoxyglucose-positron emission tomography before, during and after treatment in mature T/NK lymphomas: a study from the GOELAMS group. Ann Oncol 22: 705–711

    Article  PubMed  CAS  Google Scholar 

  5. Cheson BD (2011) Role of functional imaging in the management of lymphoma. J Clin Oncol 29: 1844–1854

    Article  PubMed  Google Scholar 

  6. Cheson BD, Pfistner B, Juweid ME, et al (2007) Revised response criteria for malignant lymphoma. J Clin Oncol 25: 579–586

    Article  PubMed  Google Scholar 

  7. Elstrom R, Guan L, Baker G, et al. (2003) Utility of FDG-PET scanning in lymphoma by WHO classification. Blood 101: 3875–3876

    Article  PubMed  CAS  Google Scholar 

  8. Feeney J, Horwitz S, Gonen M, Schoder H (2010) Characterization of T-cell lymphomas by FDG-PET/CT. AJR 195: 333–340

    Article  PubMed  Google Scholar 

  9. Gallamini A, Fiore F, Sorasio R, Meignan M (2009) Interim positron emission tomography scan in Hodgkin lymphoma: definitions, interpretation rules, and clinical validation. Leukemia & Lymphoma 50: 1761–1764

    Article  Google Scholar 

  10. Hutchings M, Loft A, Hansen M, et al (2006) Position emission tomography with or without computed tomography in the primary staging of Hodgkin’s lymphoma. Haematologica 91: 482–489

    PubMed  Google Scholar 

  11. Hutchings M, Loft A, Hansen M, et al. (2007) Clinical impact of FDG-PET/CT in the planning of radiotherapy for earlystage Hodgkin lymphoma. Eur J Haematol 78: 206–212

    Article  PubMed  Google Scholar 

  12. Juweid ME, Stroobants S, Hoekstra OS, et al (2007) Use of positron emission tomography for response assessment of lymphoma: consensus of the Imaging Subcommittee of International Harmonization Project in Lymphoma. J Clin Oncol 25: 571–578

    Article  PubMed  Google Scholar 

  13. Karam M, Ata A, Irish K, et al. (2009) FDG positron emission tomography/computed tomography scan may identify mantle cell lymphoma patients with unusually favorable outcome. Nucl Med Commun 10: 770–778

    Article  Google Scholar 

  14. Kwee TC, Kwee RM, Nievelstein RA, et al (2008) Imaging in staging of malignant lymphoma: a systematic review. Blood 111: 504–516

    Article  PubMed  CAS  Google Scholar 

  15. La Fougere C, Hundt W, Brockel N, et al. (2006) Value of PET/CT versus PET and CT performed as separate investigations in patients with Hodgkin’s disease and non-Hodgkin’s lymphoma. Eur J Nucl Med Mol Imaging 33: 1417–1425

    Article  PubMed  Google Scholar 

  16. Le Dortz L, De Guibert S, Bayat S, et al (2010) Diagnostic and prognostic impact of 18F-FDG-PET/CT in follicular lymphoma. Eur J Nucl Med Mol Imaging 37: 2307–2314

    Article  PubMed  Google Scholar 

  17. Meignan M (2010) Interim PET in lymphoma: a step towards standardization. Eur J Nucl Med Mol Imaging 37: 1821–1823

    Article  PubMed  Google Scholar 

  18. Moulin-Romsee G, Hindie E, Cuenca X, et al (2010) 18F-FDG-PET/CT bone/bone marrow findings in Hodgkin’s lymphoma may circumvent the use of bone marrow trephine biopsy at diagnosis staging. Eur J Nucl Med Mol Imaging 37: 1095–1105

    Article  PubMed  Google Scholar 

  19. Paone G, Itti E, Haioun C, et al. (2009) Bone marrow involvement in diffuse large B-cell lymphoma: correlation between FDG-PET uptake and type of cellular infiltrate. Eur J Nucl Med Mol Imaging 36: 745–750

    Article  PubMed  Google Scholar 

  20. Quarles van Ufford H, Hoekstra O, de Haas M, et al (2010) On the added value of baseline FDG-PET in malignant lymphoma. Mol Imaging Biol 12: 225–232

    Article  PubMed  Google Scholar 

  21. Raanani P, Shasha Y, Perry C, et al. (2006) Is CT scan still necessary for staging in Hodgkin and non-Hodgkin lymphoma patients in the PET/CT era? Ann Oncol 17: 117–122

    Article  PubMed  CAS  Google Scholar 

  22. Schoder H, Noy A, Gonen M, et al (2005) Intensity of 18-fluorodeoxyglucose uptake in positron emission tomography distinguishes between indolent and aggressive non-Hodgkin’s lymphoma. J Clin Oncol 23: 4643–4651

    Article  PubMed  Google Scholar 

  23. Weiler-Sagie M, Bushelev O, Epelbaum R, et al. (2010) 18F-FDG avidity in lymphoma readdressed: a study of 766 patients. J Nucl Med 51: 25–30

    Article  PubMed  Google Scholar 

  24. Wu HB, Wang QS, Wang MF, et al (2010) Utility of 18F-FDG-PET/CT for staging NK/T-cell lymphomas. Nucl Med Commun 31: 195–200

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Service de médecine nucléaire, pôle fonction image thérapeutique, CHU Henri-Mondor, Créteil, F-94000, France

    M. Meignan

Authors
  1. M. Meignan
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to M. Meignan.

About this article

Cite this article

Meignan, M. Place de la tomographie par émission de positons au F18-fluorodéoxyglucose couplée au scanner (TEP/TDM) dans le bilan initial des lymphomes de l’adulte. Oncologie 13, 571–575 (2011). https://doi.org/10.1007/s10269-011-2066-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10269-011-2066-4

Keywords

Mots clés

Search

Navigation